经皮骨整合植入物用于儿童耳道闭锁:听力学与手术结局
该回顾性病例系列分析了2014至2016年间在Lurie儿童医院接受经皮骨整合植入物(TOI)的34例耳道闭锁或小耳畸形患儿(共41耳),评估其人口学、听力学及手术结局。结果显示并发症率低,纯音平均值和噪声下言语识别显著改善,提示TOI可作为符合听力学标准患儿的治疗选择。
要点
- TOI在儿童耳道闭锁/小耳畸形中并发症率低,听力改善显著。
- 噪声下言语识别(5 dB信噪比)平均提升18.3%(95%CI 10.8%-25.9%)。
- 纯音平均值从63.7 dB改善至9.6 dB,效果显著。
核心结论
- 经皮骨整合植入物在耳道闭锁或小耳畸形患儿中并发症率低,可提供优秀的听力学结果,应作为符合听力学标准患儿的治疗选项。
研究设计与样本
- 回顾性病例系列,纳入2014年1月1日至2016年9月30日在Lurie儿童医院小耳畸形与耳道闭锁门诊接受TOI的34例患儿(共41耳),均小于18岁,随访至少6个月,术前术后进行听力学测试。
主要发现
- 34例患儿中男性13例(38%),女性21例(62%),平均年龄8.9岁(范围5-17岁)。
- 植入侧小耳畸形占39耳(95%),30耳(73%)采用改良后上头皮切口,均用于小耳畸形病例。
- 围手术期并发症1例(血清肿需引流),2例患者出现磁体部位轻微皮肤刺激和红斑,夜间移除处理器后缓解。
- 5 dB信噪比下噪声下言语识别得分从术前75.3%(SD 14.4%;范围50%-92%)提高至术后93.6%(SD 6.95%;范围80%-100%),平均改善18.3%(95%CI 10.8%-25.9%),效应量1.62(95%CI 0.95-2.29)。
- 纯音平均值从63.7 dB(SD 13.2;范围25-11)改善至9.6 dB(SD 4.9;范围5-15)。
关键数值与推荐
- 患儿均小于18岁,患有耳道闭锁或小耳畸形,随访至少6个月,术前术后接受听力学测试。
- 听力学标准:纯音平均值和噪声下言语识别(5 dB信噪比)作为主要结局指标。
临床怎么用
- 对于符合听力学标准的耳道闭锁或小耳畸形患儿,TOI可作为一种低并发症、听力改善显著的治疗选择,尤其适用于计划后期耳廓重建者,可采用改良后上头皮切口。
局限性
- 回顾性病例系列,样本量有限(34例患者,41耳),随访时间至少6个月,可能不足以评估长期并发症和耐久性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Patients with aural atresia typically have maximal conductive hearing loss, which can have negative academic and social consequences. Transcutaneous osseointegrated implants (TOIs) can potentially restore hearing on the affected side. OBJECTIVES: To review the demographic, audiological, and surgical outcomes of TOI placement in pediatric patients with aural atresia and to describe a modification in incision technique in anticipation of later auricular reconstruction. DESIGN, SETTING, AND PARTICIPANTS: This retrospective case series reviewed 41 cases of TOI placement in pediatric patients between January 1, 2014, and September 30, 2016, at Lurie Children's Microtia and Aural Atresia Clinic. Patients, all younger than 18 years and with atresia or microtia, received at least 6 months of follow-up and underwent testing before and after surgery. MAIN OUTCOMES AND MEASURES: Patient age, indication for procedure, ear sidedness, case length, incision type, complications, and other postoperative events. Audiological outcomes before and after implantation were measured using pure-tone averages and the Hearing In Noise Test for Children, presented in variable signal to noise ratios. RESULTS: In total, 46 TOIs were performed in 38 pediatric patients, but only 41 implantations in 34 patients were included in this study. Of the 34 patients, 13 (38%) were males and 21 (62%) were females, with a mean age of 8.9 (range, 5-17) years at the time of TOI placement. Microtia on the implanted side was present in 39 cases (95%). A modified posterior-superior scalp incision technique was used in 30 (73%) of 41 ears, all in cases of microtia. One perioperative surgical complication occurred: a seroma requiring drainage. Two patients developed minor skin irritation and erythema at the magnet site related to the overnight use of the processor, which resolved when removed while sleeping. The mean (SD; range) score for the Speech In Noise test at 5 dB signal to noise ratio improved from 75.3% (14.4%; range, 50%-92%) correct in unaided/preoperative condition to 93.6% (6.95%; range, 80%-100%) correct in the aided/postoperative condition. The mean improvement in score was 18.3% (95% CI, 10.8%-25.9%), with an effect size of 1.62 (95% CI, 0.95-2.29). The mean pure-tone averages (SD; range) similarly improved from 63.7 (13.2; range, 25-11) dB to 9.6 (4.9; range, 5-15) dB. CONCLUSIONS AND RELEVANCE: Transcutaneous osseointegrated implantation has a low complication rate among pediatric patients with atresia or microtia and can provide excellent audiological results. It should be included as a treatment option for this population of patients who meet audiological criteria.
引用
- Lippmann E, Pritchett C, Ittner C, et al. Transcutaneous Osseointegrated Implants for Pediatric Patients With Aural Atresia. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 29978214. doi:10.1001/jamaoto.2018.0911
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。